Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Ginposome PharmaTech is a specialized biotechnology company focused on the development of advanced drug delivery systems, particularly liposomal and lipid nanoparticle (LNP) formulations. The company provides comprehensive CRO and CDMO services for complex injections, including nanocrystals, microspheres, and mRNA delivery platforms. Ginposome leverages its proprietary technology to improve the solubility, stability, and targeting of both small molecule drugs and nucleic acid therapeutics. Their business model combines internal drug development with strategic partnerships to accelerate the commercialization of high-end generics and innovative medicines. The company is headquartered in Shanghai and operates state-of-the-art R&D and pilot manufacturing facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Ginposome PharmaTech.